SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-014823
Filing Date
2020-01-27
Accepted
2020-01-27 08:00:49
Documents
15
Period of Report
2020-01-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d875269d8k.htm   iXBRL 8-K 46170
2 EX-99.1 d875269dex991.htm EX-99.1 23299
7 GRAPHIC g875269img07.jpg GRAPHIC 5878
  Complete submission text file 0001193125-20-014823.txt   277664

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA agn-20200127.xsd EX-101.SCH 5355
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agn-20200127_def.xml EX-101.DEF 15555
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE agn-20200127_lab.xml EX-101.LAB 26347
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agn-20200127_pre.xml EX-101.PRE 16848
11 EXTRACTED XBRL INSTANCE DOCUMENT d875269d8k_htm.xml XML 10644
Mailing Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400
Business Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400 (216) 523-5000
Allergan plc (Filer) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36867 | Film No.: 20547120
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences